TROFUSE-020/GOG-3101/ENGOT-CX20: A PHASE 3, RANDOMIZED, ACTIVE-CONTROLLED, OPEN-LABEL, MULTICENTER STUDY COMPARING SACITUZUMAB TIRUMOTECAN MONOTHERAPY VS TREATMENT OF PHYSICIAN’S CHOICE AS SECOND-LINE TREATMENT FOR RECURRENT/METASTATIC CERVICAL CANCER
作者
Ritu Salani,Lin Zhongqiu,Shin Nishio,Ana Oaknin,Jean‐Emmanuel Kurtz,Giorgio Valabrega,Stefania Canova,M. Valeria Cáceres,Philipp Harter,Lucy Gilbert,Azmat Sadozye,Lilian Arruda Do Rêgo Barros,Jung-Yun Lee,Toon Van Gorp,Ingrid A Boere,Christian Marth,Radosław Mądry,Flora Zagouri,Linda Duska,Bradley J. Monk